{"id":"https://openalex.org/W4388047895","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0508","title":"508 IL-15-stimulated NK cell proliferation is greatly augmented by the anti-ADAM17 mAb Medi-1 and requires CD137","display_name":"508 IL-15-stimulated NK cell proliferation is greatly augmented by the anti-ADAM17 mAb Medi-1 and requires CD137","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388047895","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0508"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0508","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0508","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0508","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/571.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/571.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007602719","display_name":"Anders W. Matson","orcid":"https://orcid.org/0000-0001-8470-5822","observed_orcids":["https://orcid.org/0000-0001-8470-5822"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anders W Matson","raw_affiliation_strings":["University of Minnesota, Saint Paul, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Saint Paul, MN, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001181284","display_name":"Robert Hullsiek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Hullsiek","raw_affiliation_strings":["University of Minnesota, Saint Paul, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Saint Paul, MN, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038034790","display_name":"Kate J. Dixon","orcid":"https://orcid.org/0000-0003-2548-7022","observed_orcids":["https://orcid.org/0000-0003-2548-7022"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kate Dixon","raw_affiliation_strings":["University of Minnesota, Saint Paul, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Saint Paul, MN, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040090483","display_name":"Sam C. Wang","orcid":"https://orcid.org/0000-0003-3626-5273","observed_orcids":["https://orcid.org/0000-0003-3626-5273"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sam Wang","raw_affiliation_strings":["University of Minnesota, Saint Paul, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Saint Paul, MN, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ryan R Friess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan R Friess","raw_affiliation_strings":["University of Minnesota, Saint Paul, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Saint Paul, MN, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022682897","display_name":"Bruce K. Walcheck","orcid":"https://orcid.org/0000-0003-1933-3887","observed_orcids":["https://orcid.org/0000-0003-1933-3887"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce Walcheck","raw_affiliation_strings":["University of Minnesota, Saint Paul, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Saint Paul, MN, USA","institution_ids":["https://openalex.org/I130238516"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I130238516"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A571","last_page":"A572"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8820000290870667},{"id":"https://openalex.org/keywords/il-15","display_name":"IL-15","score":0.8629999756813049},{"id":"https://openalex.org/keywords/adam17","display_name":"ADAM17","score":0.9470000267028809},{"id":"https://openalex.org/keywords/4-1bb","display_name":"4-1BB","score":0.949999988079071},{"id":"https://openalex.org/keywords/nk-cell-proliferation","display_name":"NK cell proliferation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/nk-cell-expansion","display_name":"NK cell expansion","score":0.8159999847412109},{"id":"https://openalex.org/keywords/nk-cell-exhaustion","display_name":"NK cell exhaustion","score":0.7170000076293945},{"id":"https://openalex.org/keywords/il-15-receptor-alpha","display_name":"IL-15 receptor alpha","score":0.6899999976158142},{"id":"https://openalex.org/keywords/cd69","display_name":"CD69","score":0.7210000157356262},{"id":"https://openalex.org/keywords/cd25","display_name":"CD25","score":0.8050000071525574},{"id":"https://openalex.org/keywords/adoptive-nk-cell-therapy","display_name":"adoptive NK cell therapy","score":0.6430000066757202},{"id":"https://openalex.org/keywords/cytokine-inhibition","display_name":"cytokine inhibition","score":0.41100001335144043},{"id":"https://openalex.org/keywords/nsg-mice","display_name":"NSG mice","score":0.5329999923706055},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7699999809265137},{"id":"https://openalex.org/keywords/ex-vivo-nk-cell-expansion","display_name":"ex vivo NK cell expansion","score":0.550000011920929}],"concepts":[{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.6405612230300903},{"id":"https://openalex.org/C28651165","wikidata":"https://www.wikidata.org/wiki/Q4259786","display_name":"Lymphokine-activated killer cell","level":5,"score":0.5603099465370178},{"id":"https://openalex.org/C149532602","wikidata":"https://www.wikidata.org/wiki/Q2409681","display_name":"Interleukin 12","level":4,"score":0.5494500994682312},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5371848344802856},{"id":"https://openalex.org/C183315844","wikidata":"https://www.wikidata.org/wiki/Q6155969","display_name":"Janus kinase 3","level":5,"score":0.5350369811058044},{"id":"https://openalex.org/C98119934","wikidata":"https://www.wikidata.org/wiki/Q14907167","display_name":"Interleukin 15","level":4,"score":0.460705429315567},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.4562138617038727},{"id":"https://openalex.org/C2780249625","wikidata":"https://www.wikidata.org/wiki/Q14913226","display_name":"CD137","level":4,"score":0.44867607951164246},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4397146999835968},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4311069846153259},{"id":"https://openalex.org/C206191192","wikidata":"https://www.wikidata.org/wiki/Q17149636","display_name":"NK-92","level":5,"score":0.4260501265525818},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.4189490079879761},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36578959226608276},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.35554608702659607},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3460698127746582},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3418240547180176},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3266105055809021},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.2203955352306366},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.20088663697242737},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.13564234972000122},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0508","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0508","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0508","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/571.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:527cf39e38e14cc6a9def274ac442af0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/527cf39e38e14cc6a9def274ac442af0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0508","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0508","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0508","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/571.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388047895.pdf","grobid_xml":"https://content.openalex.org/works/W4388047895.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400995632","https://openalex.org/W7106286773","https://openalex.org/W3183414980","https://openalex.org/W4416450986","https://openalex.org/W4416451007","https://openalex.org/W7126246198","https://openalex.org/W2953813792","https://openalex.org/W2950042160","https://openalex.org/W2143027120","https://openalex.org/W2110999048"],"abstract_inverted_index":{"Background":[0],"Natural":[1],"killer":[2],"(NK)":[3],"cells":[4,17,41,53,80,113,128,210,233,263,274,337],"are":[5],"innate":[6],"cytolytic":[7],"lymphocytes":[8],"that":[9,77,147,254,291,324,363],"can":[10],"directly":[11],"and":[12,58,114,135,165,184,219,225,264,331,376,395,440],"rapidly":[13,64],"kill":[14],"malignantly":[15],"transformed":[16],"without":[18],"clonal":[19],"expansion.":[20],"While":[21],"NK":[22,40,52,79,100,112,121,127,149,177,196,209,232,273,296,316,336,349,380],"cell":[23,69,101,122,150,178,197,297,317,350,381],"adoptive":[24],"transfer":[25],"has":[26],"shown":[27],"clinical":[28],"benefits":[29],"in":[30,81,103,166,275,315,354,383,386],"cancer":[31,384],"patients,":[32,385],"this":[33,329],"approach":[34],"requires":[35],"cytokine":[36],"support":[37],"for":[38,137,328],"the":[39,191,310,332,342,355,373,416,421,431,436,444],"to":[42,94,392],"persist,":[43],"which":[44,243],"IL-15":[45,162,213,236,283,300,353],"is":[46,86,152,251,256,290,306,326],"commonly":[47],"used.":[48],"Cytokine":[49],"stimulation":[50,266],"of":[51,68,203,221,313,335,357,379,420,423,443,446],"activates":[54],"ADAM17":[55,96],"(a":[56],"disintegrin":[57],"metalloproteinase-17).":[59],"This":[60,173],"membrane-associated":[61],"protease":[62],"then":[63],"cleaves":[65],"a":[66,74,82,87,167,245,257],"number":[67],"surface":[70],"receptors,":[71],"serving":[72],"as":[73,239],"regulatory":[75],"checkpoint":[76],"restrains":[78],"polyfunctional":[83],"manner.":[84],"Medi-1":[85,156,285,339,364],"human":[88],"IgG1":[89],"mAb":[90,345,398],"utilized":[91],"by":[92,155,199,282,299,319,338,352,371,388,415,435],"us":[93],"block":[95],"function.":[97],"Methods":[98],"Human":[99],"expansion":[102,151],"vivo":[104,120],"was":[105,240,404,413,433],"performed":[106],"using":[107],"NSG":[108],"mice":[109],"administered":[110],"enriched":[111,126],"rhIL-15":[115,141],"\u00b1":[116,140,142,214],"Medi-1.":[117,143,200,215,358],"For":[118,427],"ex":[119,158],"expansion,":[123,374],"PBMCs":[124],"or":[125],"were":[129,206,228],"labeled":[130],"with":[131,212,235,406],"CellTrace":[132],"Violet":[133],"dye":[134],"cultured":[136],"7":[138],"days":[139],"Results":[144],"We":[145],"show":[146],"IL-15-driven":[148,195],"markedly":[153],"enhanced":[154,194,280,348],"treatment":[157],"vivo,":[159],"including":[160],"under":[161],"limiting":[163],"conditions,":[164],"xenograft":[168],"mouse":[169],"model":[170],"(figure":[171,248,286,302],"1).":[172],"did":[174],"not":[175],"cause":[176],"exhaustion":[179],"based":[180],"on":[181,190,208,231,261,272,309],"phenotypic":[182],"profiling":[183],"functional":[185],"assays.":[186],"Here,":[187],"we":[188],"focus":[189],"mechanism":[192],"underlying":[193],"proliferation":[198,281,298,318,334,351],"Various":[201],"markers":[202],"lymphocyte":[204],"activation":[205],"examined":[207],"stimulated":[211,234],"The":[216,411],"expression":[217],"rate":[218],"level":[220],"CD69,":[222],"CD25":[223],"(IL-2R\u03b1),":[224],"CD215":[226],"(IL-15R\u03b1)":[227],"significantly":[229],"increased":[230],"+":[237,284],"Medi-1,":[238],"CD137":[241,255,271,314,325],"(4\u20131BB),":[242],"demonstrated":[244],"dramatic":[246],"upregulation":[247],"2).":[249],"It":[250],"well":[252],"established":[253],"key":[258],"co-activation":[259],"receptor":[260],"T":[262],"its":[265],"enhances":[267],"their":[268,279,390],"proliferation.":[269],"Inhibiting":[270],"various":[276],"manners":[277],"blocked":[278,295],"3).":[287,303],"Of":[288],"interest":[289],"4\u20131BB":[292],"inhibition":[293],"also":[294],"alone":[301],"Currently":[304],"there":[305],"little":[307],"information":[308],"physiological":[311],"role":[312],"IL-15.":[320],"Our":[321,360],"data":[322,361],"reveal":[323,362],"necessary":[327],"process":[330],"augmented":[333],"treatment.":[340],"Moreover,":[341],"anti-4\u20131BB":[343,396],"agonistic":[344],"urelumab":[346],"further":[347],"presence":[356],"Conclusions":[359],"may":[365],"have":[366],"an":[367],"important":[368],"therapeutic":[369],"use":[370],"increasing":[372],"persistence,":[375],"effector":[377],"functions":[378],"therapies":[382],"part":[387],"enhancing":[389],"sensitivity":[391],"IL-15,":[393],"IL-2,":[394],"agonist":[397],"therapies.":[399],"Ethics":[400],"Approval":[401],"Peripheral":[402],"blood":[403],"collected":[405],"consent":[407],"from":[408],"healthy":[409],"donors.":[410],"protocol":[412,432],"approved":[414,434],"Institutional":[417,437],"Review":[418],"Board":[419],"University":[422,445],"Minnesota":[424,447],"(Protocol:":[425,448],"9708M00134).":[426],"experiments":[428],"involving":[429],"mice,":[430],"Animal":[438],"Care":[439],"Use":[441],"Committee":[442],"2112\u201339650A).":[449]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}